BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang EJ, Choi YJ, Kim JS, Kim ST, Park KH, Choi IK, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma: Chemotherapy in refractory colon cancer. Asia-Pacific Journal of Clinical Oncology 2010;6:286-91. [DOI: 10.1111/j.1743-7563.2010.01334.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hompes D, D’Hoore A, Wolthuis A, Fieuws S, Mirck B, Bruin S, Verwaal V. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. J Surg Oncol. 2014;109:527-532. [PMID: 24375059 DOI: 10.1002/jso.23546] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 8.5] [Reference Citation Analysis]
2 Kim ST, Kim TW, Kim KP, Kim TY, Han SW, Lee JY, Lim SH, Lee MY, Kim H, Park YS. Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer. Cancer Res Treat 2015;47:790-5. [PMID: 25672574 DOI: 10.4143/crt.2014.126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kannen V, Garcia SB, Stopper H, Waaga-gasser AM. Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy? Pharmacology & Therapeutics 2013;139:87-94. [DOI: 10.1016/j.pharmthera.2013.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
4 Petrelli F, Ghidini A, Inno A, Barni S. Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesis. Anticancer Drugs 2016;27:488-95. [PMID: 27186954 DOI: 10.1097/CAD.0000000000000363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Saint A, Evesque L, Falk AT, Cavaglione G, Montagne L, Benezery K, Francois E. Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canal. Cancer Med 2019;8:6853-9. [PMID: 31524335 DOI: 10.1002/cam4.2558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]